Protein arginine (N)-methyl transferase 7 (PRMT7) as a potential target for the sensitization of tumor cells to camptothecins

FEBS Lett. 2008 Apr 30;582(10):1483-9. doi: 10.1016/j.febslet.2008.03.031. Epub 2008 Mar 31.

Abstract

PRMT7 belongs to the protein arginine methyl-transferases family. We show that downregulation of PRMT7alpha and beta isoforms in DC-3F hamster cells was associated with increased sensitivity to the Top1 inhibitor camptothecin (CPT). This effect was not due to a change in Top1 contents or catalytic activity, or to a difference in the reversal of DNA breaks. Overexpression of PRMT7alpha and beta in DC-3F cells had no effect on CPT sensitivity, whereas it conferred a resistance to DC-3F/9-OH-E cells for which both isoforms are reduced by two- to three-fold as compared to DC-3F parental cells. Finally, downregulation of the human PRMT7 could also sensitize HeLa cells to CPT, suggesting that it could be used as a target to potentiate CPT derivatives.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Camptothecin / pharmacology*
  • Cell Line, Tumor
  • Cricetinae
  • Down-Regulation
  • Drug Resistance, Neoplasm / genetics*
  • HeLa Cells
  • Humans
  • Isoenzymes / genetics
  • Isoenzymes / metabolism
  • Methyltransferases / genetics*
  • Methyltransferases / metabolism
  • Neoplasms / enzymology*
  • Oligonucleotides, Antisense / genetics
  • Protein-Arginine N-Methyltransferases

Substances

  • Antineoplastic Agents
  • Isoenzymes
  • Oligonucleotides, Antisense
  • Methyltransferases
  • PRMT7 protein, human
  • Protein-Arginine N-Methyltransferases
  • Camptothecin